All News

ViewPoints: J&J keeps the world waiting

Ref: ViewPoints Desk

Tags: ViewPoints J&J Clinical Research (R&D) Corporate Affairs Ad26.COV2-S

Qurient Enrolls First Patient in Q702 U.S. Phase 1 Study

Ref: Business Wire

Tags: Press Release Qurient Clinical Research (R&D)Q702

Unprecedented international achievement for Panaxia: selected as one of the four main winners in the French government tender for regulation of the medical cannabis industry

Ref: PR Newswire

Tags: Press Release neuraxpharm Panaxia ANSM Corporate Affairs cannabidiol dronabinol

ViewPoints: Novartis preaches caution for 2021, reveals Leqvio delay

Ref: ViewPoints Desk

Tags: ViewPoints Novartis Corporate Affairs Regulatory Affairs Leqvio

Update on TRAUMAKINE development

Ref: Faron Pharmaceuticals

Tags: Press Release Faron Pharmaceuticals COVID-19 FDA Regulatory Affairs Traumakine

Aclipse Therapeutics Announces $2.2 Million Grant from UK’s Medical Research Council for Development of M102

Ref: Business Wire

Tags: Press Release Aclipse Therapeutics Corporate Affairs M102

Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium 2021

Ref: GlobeNewswire

Tags: Press Release Freeline Clinical Research (R&D) Medical Affairs EAHAD FLT180a FLT201

Sweden wants clarity on vaccine doses before paying Pfizer

Ref: National Post

Tags: NewsPoints BioNTech Pfizer COVID-19 Immunisation European Commission Marketing & Sales

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Ref: CNW

Tags: Press Release Nova Clinical Research (R&D)psilocybin valproic acid

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet (copper Cu 64 dotatate injection)

Ref: GlobeNewswire

Tags: Press Release Curium RadioMedix Marketing & Sales